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No Long-term Excess Mortality after Measles Infection: A Community Study 
from Senegal 
Pete@aby,'.* Badar&amb,' Marc Andersen: and Francoi &mondon' 
Because measles immunization has been found in all studies to reduce mortality with more than the share 
of deaths attributed to acute measles, the authors examined mortality after measles infection in a study in a 
rural area of Senegal that included 6,924 unimmunized children, of whom 1,118 developed measles. Age- 
adjusted post-measles mortality was similar to the mortality of unvaccinated, uninfected children (mortality 
ratio (MR) = 1.04, 95% confidence interval (CI) 0.80-1.35). When controlling for source of infection, mortality 
rate was significantly different for children who contracted measles from a person outside the home (index 
cases vs. unvaccinated, uninfected MR = 0.27, 95% CI 0.09-0.85) and for children infected at home 
(secondary cases vs. unvaccinated, uninfected MR = 1.1 O, 95% CI 0.80-1 51). Hence, secondary cases had 
markedly higher long-term mortality than did index cases (MR = 4.13, 95% CI 1.26-13.58). These estimates 
were essentially unchanged when the effects of season, period, separation from mother, size of community, 
and size of compound were investigated using a multivariate Cox regression model. The authors conclude that 
measles infection was not associated with increased mortality after the acute phase of infection and that index 
cases had lower mortality than uninfected, unvaccinated children. The reduction in mortality after measles 
immunization can therefore not be explained by the prevention of post-measles mortality. Am J Epidemiol 
immunization; infection; measles 
1996;143:1035-41. 
Studies from West Africa have reported measles 
infection to be associated with major delayed mortality 
after the acute phase (1-3). In studies from many 
developing countries, including Guinea-Bissau (2, 4), 
Zaire (5), Senegal (6), Bangladesh (7), and Haiti (S), 
measles immunization has been associated with reduc- 
tions in overall childhood mortality of 30 percent or 
more, which is considerably more than the share of all 
deaths attributed to acute measles. This extra benefit 
from measles immunization has been ascribed to the 
prevention of the negative long-term consequences of 
measles infection (2, 3, 7). 
However, studies of long-term mortality after mea- 
sles infection have had small numbers and have not 
adjusted for possible confounding factors, particularly 
the impact of immunization status (3). Furthermore, to 
our knowledge, no study has examined prospectively 
the timing, extent, and risk factors associated with 
excess mortality. 
Studies of long-term mortality after measles have 
acquired additional interest, because recent studies of 
high-titer measles vaccines from West Africa and 
Haiti have reported increased mortality for the recip- 
ients of high-titer vaccines corrj'pared with children 
who received standard low-titer or medium-titer mea- 
sles vaccine (6, 9, 10). This tbdency has not been 
found in areas with low background mortality (1 1,12). 
It has been speculated (10, 1d>' that high-titer vaccine 
could possibly have a long-term negative impact on 
the immune system, as also suspected after measles 
infection. The present study examines long-term sur- 
vival after measles infection in a rural area of Senegal, 
Niakhar, where measles transmission and acute mor- 
tality was studied between 1983 and 1986 (14, 15). 
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MATERIALS AND METHODS 
Background 
The study area, which has a population of 24,000 
inhabitants, has been under demographic surveillance 
since March 1983 (14). The demographic surveillance 
system included annual censuses in all compounds in 
the study area to detect new births, migrations, mar- 
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riages, and deaths. Information on infections (measles 
and whooping cough) and immunizations was also 
obtained on this occasion. The area is populated al- 
most exclusively by the Sereer, who live in com- 
pounds with an average of 14 persons. Larger com- 
pounds are usually divided into multiple separate 
households. Within a household, people may sleep in 
different huts. 
Investigation of measles epidemiology and 
measles immunization 
As described in detail elsewhere (14, 15), all cases 
of measles reported in the annual census were inves- 
tigated during home visits to determine the source of 
infection and the pattem of transmission within the 
compound. A total of 1,500 cases were detected in the 
period from 1983 to L9,86. As a result of long intervals 
between epidemics of measles, the age at infection 
proved to be high (14-16). The present study is based 
primarily on parent11 reports. However, these reports 
are likely to be cor@ct as there are very few reports of 
reinfections with mkasles among children with a pre- 
vious history of measles; during 1987-1990, when 
virtually all cases were confirmed by a physician (17), 
62 children who had measles during 1983-1986 were 
exposed to m-easles again znd only om child devel- 
oped measles (15). There are other indications that 
parental diagnoses are reliable, i.e,, high secondary 
attack rates and high cumulative incidence (14, 16). 
The first case (index case) was identified, and the 
mother was asked about the probable source of infec- 
tion. Children were classified as secondary cases if 
their rash occurred 6 or more days following the rash 
of an index case. In the main analysis, we have dis- 
tinguished only between index and secondary cases in 
the compound. Exposure was classified for 87.3 per- 
cent of the documented cases. Children with unknown 
exposure status had mostly contracted measles outside 
the study area (14). 
Measles vaccine coverage was poor during the pe- 
riod studied (14). A few well-defined campaigns were 
carried out in certain villages by development projects, 
mainly during the dry seasons in 1979, 1981, 1982, 
and 1983. Information on immunizations both inside 
and outside the study area was obtained in the annual 
censuses. 
Study population: measles cases and controls 
The present study compares post-measles mortality 
of unimmunized children with mortality of unimmu- 
nized children who had not had measles. In order to 
maximize the number of controls, all children were 
included as controls until they developed measles, 
received immunization, or were censored for other 
reasons. Hence, children who received measles immu- 
nization or developed measles infection were excluded 
from the control group from the date of immunization 
or infection. 
In previous analyses of the determinants of mortal- 
ity (14, 15), children who died within 6 weeks were 
considered acute deaths. The present study examines 
post-measles mortality, i.e., the mortality from 43 days 
after measles. Because few children had measles be- 
fore 6 months of age (14), the comparison was only 
made from 6 months of age. After the initiation of the 
national immunization campaign at the end of 1986, 
mortality levels changed dramatically in the study 
area. It was therefore decided to censar follow-up in 
December 1986. Post-measles cases were followed 
from 43 days after infection to death, migrat’ lion, or 
December 1986. Controls were followed from the first 
census in 1983 or age 6 months, if born during the 
period of surveillance, to death, immunization against 
measles, migration, or December 1986. 
In the initial census in 1983, information on measles 
infection prior to the study was only obtained system- 
atically for children born since 1978. Because we 
wanted to analyze mortality after 6 months of age for 
children who had not had measles prior to the study, 
the analysis was restricted to children bom from Jan- 
uary 1978 onward. Children bom during the study 
until March 1986 were also included in the analysis. 
The youngest child who had measles in the period 
1983-1986 was born in March 1986. A total of 8,892 
children bom between January 1978 and March 1986 
were registered in the study area. After exclusion of 
children registered after December 1, 1986, children 
who were censored before 6 months of age, and chil- 
dren who had measles or had been immunized before 
entry, 6,924 children remained for the survival analy- 
sis. Children who were immunized against measles 
before the end of the study were excluded from the day 
they received measles vaccine. Of the 1,500 measles 
cases registered between 1983 and 1986 (14, 15), 
1,118 belonged to the group born from January 1978 
onward and who had not been immunized against 
measles. 
Statistical methods 
Crude analyses of differences in long-term post- 
measles mortality were based on deaths in relation to 
person-years-at-risk in different age groups. Multiva- 
riate Cox regression analyses (1 8) were used to control 
for the effect of background factors. Age is used as the 
time scale in the Cox regression model. The analyses 
were stratified for sex to allow for non-proportional 
mortality for each sex. A child was considered under 
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risk from 6 months of age or from the age at entry if 
after 6 months of age, until death, migration, or De- 
cember 1986. A child with measles was considered at 
risk for post-measles mortality from 42 days after the 
onset of measles infection. Effects are expressed as 
mortality ratios and 95 percent confidence intervals. 
The post-measles mortality effect was modeled using 
a time-dependent covariate. The effect of time-since- 
measles (time-dependent: 0-12 months, > 12 months), 
and risk factors for severity of acute measles infection 
(time-independent: sex, age at infection, intensity of 
exposure (IO), generation within the compound (lo), 
and cross-sex transmission (1 1)) have been modeled 
by the interaction of the factor and the time-dependent 
post-measles variable. The analysis also included fac- 
tors known to affect measles incidence (time-indepen- 
dent: size of village) and child mortality (time-depen- 
dent: season (July-October (rain) vs. November-June 
(dry)), and separation from the mother; time-indepen- 
dent: size of compound, matemal education, and pe- 
riod (first and second half of the period from 1983 to 
1986)). To evaluate the effect of exposure, a separate 
analysis was performed where children with unknown 
exposure were excluded. Because the study included 
cases between 1983 and 1986 and follow-up was cen- 
sored in December 1986, maximum follow-up was 3.7 
years. The median follow-up after the acute phase of 
measles was 523 days (range, I-1,348 days). 
RESULTS 
Study population and incidence of measles 
In the study from 1983 to 1986 of acute measles 
mortality (14), there were 1,500 cases, of whom 1,118 
were unimmunized children born after January 1978. 
The median age at infection was 43 months. For 
unimmunized children, the cumulative incidence of 
measles was 19.2 percent and 33.2 percent, respec- 
tively, at ages 3 and 5 years. At age 3 years, there was 
no difference in cumulative incidence (20.3 percent vs. 
19.2 percent) using data from the children born during 
the study and the children bom before the beginning of 
the study in March 1983. The acute case fatality ratio 
was 8.6 percent for unh"mnized children (table 1); 
secondary cases had a much higher case fatality ratio 
than index cases in the compound (mortality ratio 
(MR) = 2.48, 95 percent confidence interval (CI) 
Of the 1,118 unimmunized measles cases born after 
January 1978, 96 children died in the acute phase and 
13 had no post-measles follow-up because they were 
guests or moved at the time of measles infection, 
leaving 1,009 children to be included in the post- 
measles survival analysis; 199 children were index 
cases, 695 were secondary cases, and 185 had un- 
known exposure. 
1.22-5.04). 
Crude analysis of post-measles mortality 
Mortality in the post-measles period and in the con- 
trol group of unimmunized children is indicated in 
table 2. There was no excess mortality in the post- 
measles groups compared with unvaccinated controls 
(MR = 1.04, 95 percent CI 0.80-1.35) (table 2). 
Because we have previously found (14) that intensity 
of exposure was important for acute mortality and 
mortality during the first year after infection, long- 
term survival has also been examined in relation to the 
intensity of exposure to measles. Index cases had 
significantly lower mortality than community controls 
without a history of measles (MR = 0.27,'95 percent 
CI 0.09-0.85), whereas secondary cases bad the same 
mortality as controls (MR = 1.10, 95; percent CI 
0.80-1.51). Hence, secondary cases hpd markedly 
higher long-term mortality than did index cases (MR 
= 4.13, 95 percent CI 1.26-13.58). Postmortem inter- 
views (6) have shown that most childhood deaths in 
Niakhar are related to diarrhea, malaria, pneumonia, 
and malnutrition. Apparently, index cases had lower 
mortality for all of these causes. However, with the 
TABLE I. Acute case fatality ratios for measles cases according to exposure, Niakhar, Senegal, 
1983-1986 
No. of deathsho. of cases (case fatality ratio) 
Age 
group Index Secondary Other cases* Ali cases 
3/35 (0,086) 
45/389 (O. 11 6) 6-23 months 4/61 (0.066) 30/212 (0.142) 11/115 (0.096) 
45/506 (0.089) 2-4 years 4/95 (0.042) 351345 (0.101) 6/66 (0.091) 
5-9 years 0/52 (0.0) 3/118 (0.025) O118 (0.0) 3/188 (0.016) 
Total 81212 (0.038) 70/698 (0.100) 18/208 (0.087) 96/1,118 (0.086) 
* Cases infected at a health center/hospital or cases without information on exposure, Most of these cases had 
05 months 014 (0.0) 2/23 (0.087) 1/9 (0.111) 
measles outside the study area. 
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TABLE 2. Numbers of deaths, person-years-at risk, and annual mortality rates for post-measles cases, 
according to exposure, and unvaccinated controls, Niakhar, Senegal, 1983-1 986 
Age (annual mortality rate) 
No. of deathdperson-years-at-risk (no.*) 
Controls All cases Index Secondary Other casest group 
Girls 
6-23 months 0/13.1 (21) 5/57.0 (81) 8/24.5 (54) 13/94.3 (156) 188/2,231.2 (2,345) 
2-4 years W68.9 (59) 12/214.5 (212) 4ff0.3 (68) 18/353.7 (339) 113/2,766.4 (2,165) 
(0.000) (0.088) (0.331) (0.138) (0.084) 
(0.029) (0.056) (0.057) (0.051) (0.041) 
0/15.4 (18) 31236.9 (205) 15/1,272.3 (833) 
(O/OOO) (0.01 3) (0.012) 
5-9 years i/48.1'(42) 
(0.021) 
BOYS 
6-23 months 0/20.6 (32) 
2-4 years OffO.4 (71) 
5-9 years 0194.0 (60) 
(0.000) 
(0,000) 
(0.000) 
( 1  
Total 
5173.4 (145) 
(0.012) 
7/76.4 (1 1 1 )  
(0.092) 
13/254.3 (241 
2/177.1 (150) 
(0.051) 
(0.01 1) 
3/30,3 (47) 101127.3 (190) 186/2,378.1 (2,483) 
(0.099) (0.079) (0.078) 
3ff0.4 (70) 16/395.1 (382) 158/2,724.9 (2,198) 
(0.043) (0.040) (0.058) 
0/23.0 (22) W294.1 (232) 9/1,273.8 (808) 
(0.000) (0.007) (0.007) 
.? 6-23 months 0/33.7 (53) 12/133.3 (192) 11E4.5 (101) 23/221.5 (346) 374/4,609.3 (4,828) 
d (0.000) (0.090) (0.202) (0.104) (0.081) 
1 2-4 years a139.3 (130) 25/468.8 (453) 7A40.7 (138) 34ff48.8 (721) 271/5,491.3 (4,363) 
(0.0 14) (0.053) (0.050) (0.045) (0.049) 
i 5-9 years 11142.1 (102) 41350.5 (295) Oi38.5 (40) 5/531.1 (437) 24/2,546.0 (1,641) 
* (0.007) (0.01 1) (0.000) (0,009) (0,009) 
* Number of children who contributed to person-years-at-risk in this age group. Because a child may have 
contributed to follow-up time in several age groups or may have been a control first only t9 become a case later, 
numbers do noi add up to the total number of children in the study. 
t Cases without information on exposure. Most of these cases had measles outside the study area. 
limited number of index cases, there was little power 
to detect differences by type of pathology. 
Because girls in Niakhar have been found to have 
higher acute measles mortality (15) and to have higher 
mortality after high-titer measles vaccination (6), dif- 
ferences in post-measles mortality by sex were also 
examined (table 2). Although not a significant differ- 
ence, girls tended to have higher post-measles mortal- 
ity than boys (MR = 1.47, 95 percent CI 0.89-2.44). 
However, when the children were followed for another 
5 years, to February 1992, there were 21 male deaths 
and eight female deaths among post-measles cases, of 
whom at least nine had been immunized during the 
campaign in 1986-1987. Hence, there was no sign of 
a long-term difference in post-measles mortality by 
sex. 
Multivariate analyses 
Season and separatioa from mother were significant 
determinants of mortality. Neither size of compound, 
size of village, period, maternal education, age at 
infection, time-since-measles, nor interaction between 
sex and post-measles mortality were significant. Ad- 
justing for the significant background factors (table 3), 
tl h e mortality ratio for all post-measles cases was 1.04 
(95 percent CI 0.80-1.35) compared with uninfected 
children. Because age was the time scale and the Cox 
model was stratified for sex, estimates were also ad- 
justed for age and sex. There was no significant dif- 
ference between mortality ratios for post-measles girls 
(MR = 1.34, 95 percent CI 0.94-1.93) and post- 
measles boys (MR = 0.81, 95 percent CI 0.55-1.20) 
(likelihood-ratio test: chi-square = 3.49, degrees of 
freedom (df) = 1, p = 0.062). Neither cross-sex 
transmission nor generation was associated with sig- 
nificant variation in post-measles mortality .levels 
among secondary cases. 
When only measles cases with known exposure 
were included, the mortality ratio for index and sec- 
ondary cases compared with uninfected children was 
O 94 (95 percent CI 0.69-1.28). When the interaction 
b L tween post-measles mortality and exposure was in- 
cluded (table 3), it was found that the estimates were 
significantly different (likelihood ratio test: chi-square 
= 8.23, df = 1, p < O.Ol), with index cases having 
lower mortality (MR = 0.28, 95 percent CI 0.09- 
0.87) than unvaccinated controls and secondary cases 
having a mortality ratio similar to that of controls (MR 
= 1.14, 95 percent CI 0.83-1.57). 
Am J Epidemiol Vol. 143, No. 10, 1996 
No Long-term Excess of Mortality after Measles Infection 1039 
TABLE 3. Multivariate Cox regression analysis of the mortality ratios (95% confidence intervals (CI)) 
for post-measles cases compared with unvaccinated controls, controlling for background factors, 
Niakhar, Senegal, 1983-1986 
Case status All measles cases Only cases with known exposure 
95% CI Mortality Iati0 95% CI 
or Morlality 
background factor ralio 
Baseline: no measles 1 .o0 1 'O0 
Post-measles 1 .O4 0.80-1 -35 
Index cases 0.28 0.09-0.a7 
Secondary cases 1.14 0.83-1 57 
Season 
Baseline: dry 
Rainy 
1 ,o0 1 .o0 
1.73 1.50-2.00 1.72 1.49-1 -99 
Separation from mother 
Baseline: with mother 1.00 1 .o0 
Not with mother 2.44 1.54-3.86 2.05 1.22-3.42 
DISCUSSION 
Several studies have suggested that measles is asso- 
ciated with delayed mortality (1-3, 7). Post-measles 
excess mortality has been assumed to explain why 
measles immunization reduces mortality with more 
than the share of all deaths attributed to acute measles 
(2, 3, 7). Our observations from rural Senegal contra- 
dict these assumptions. Among children who had mea- 
sles between 1983 and 1986, post-measles cases did 
not have higher mortality than unimmunized controls. 
Adjustment for risk factors for child mortality made no 
difference to the mortality rate ratios between post- 
measles cases and unvaccinated, uninfected controls 
(table 3). 
Apart from possible misclassifications in the origi- 
nal assessment of exposure status (14), there seem to 
be few methodological reasons to question the obser- 
vation that index cases had significantly lower post- 
measles mortality than secondary cases. However, the 
comparison of post-measles cases with uninfected, 
unimmunized children could be biased if many unre- 
ported measles deaths, measles cases, or measles im- 
munizations had occurred in the comparison group. 
Unreported measles deaths in the comparison group 
would mean that post-measles cases did have higher 
mortality than uninfected children. However, measles 
disease is a well-recognized disease in this area (14- 
16), and deaths from clinical measles are unlikely to 
have been missed, because interviews about the cause 
of death were conducted with the parents of al1 chil- 
dren who died. If connected with high mortality, many 
subclinical measles infections could lead to an exag- 
gerated mortality rate in the comparison group because 
subclinical cases would only be found in this group. 
However, subclinical cases are milder and most occur 
before 6 months of age while the children still have 
maternal antibodies (19) and would therefore not af- 
fect the present comparison from 6 months of age. 
Because the cases detected during the study did not 
have excess mortality after measles, it seems unlikely 
that the reclassification of controls misclassified as 
uninfected would fundamentally change the mortality 
ratio between post-measles cases and uninfected chil- 
dren. 
In a study conducted in Niakhar between 1987 and 
1990, 33 percent of the "uninfected, unimmunized" 
children exposed to measles had antibodies to measles 
(17). These children were significantly older, had 
lower levels of measles antibodies, and higher second- 
ary attack rates after exposure to measles at home than 
other children with documented immunization and 
measles antibodies. Because children are expected to 
have higher antibody levels and b$tter protection after 
natural measles, it seems most likely that these unin- 
fected, unimmunized children acguired measles anti- 
bodies through undocumenteq jmmunization during 
campaigns (6) or outside the study area in the past. 
Although many of these immunizations may have 
been a result of the accelerated immunization cam- 
paigns in the beginning of 1987 (6), undocumented 
immunizations may also have occurred in the 1983- 
1986 period covered by the present study. Measles 
immunization is associated with low mortality (6, 7), 
so that adjustment for an important underreporting of 
immunizations would niean higher mortality among 
unimmunized, uninfected children compared with 
post-measles cases. 
Given annual reporting of the measles cases, the 
delay between infection and subsequent death could 
have been misreported by the parents with the effect of 
increasing acute mortality and reducing post-measles 
mortality. However, parents or guardians were asked 
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specifically about the delay between measles disease 
and death. Furthermore, a similar reporting bias could 
not produce low mortality for index cases in both the 
acute phase (table 1) and the post-measles period 
(table 2). 
The age at infection was high in the present com- 
munity study and this could have influenced the esti- 
mate of post-measles mortality. There was no interac- 
tion between age at measles infection and post- 
measles mortality. However, post-measles mortality 
could be somewhat greater for children who had mea- 
sles at an early age (table 2). Only larger studies will 
be able to assess whether young age at infection is 
important for the long-term impact of measles. 
The contrast between the present study and previous 
studies that have reported higher post-rneasles mortal- 
ity (1-3) is hard to judge because these studies mainly 
compared post-measles cases and immunized controls. 
For example, post;measles cases in Guinea-Bissau had 
significantly higher mortality than community controls 
who had receive&measles vaccine (2). However, com- 
pared with unimhunized controls, post-measles cases 
tended to have &wer mortality (MR = 0.45, 95 per- 
cent CI O. 14-fi43)) (2). Subsequent studies from 
Guinea-Bissau, Senegal, Bangladesh (unpublished ob- 
servations), and Burundi (20) have likewise failed to 
find higher post-measles mortality. 
Index cases h2d very !ow post-measles mortality 
(table 2). Even allowing for some misclassification of 
infection and immunization status, it ,seems unlikely 
that the mortality level in the group of uninfected, 
unimmunized children would come near the level 
among post-measles index cases. Because index cases 
had low mortality in the acute phase of measles, low 
post-measles mortality among index cases cannot be 
due to a “selection” of stronger children, the weak 
ones having died already during measles infection. We 
may therefore have to look for another explanation of 
the low post-measles mortality among index cases. 
While measles may be associated with adverse long- 
term consequences in some individuals, e.g., aggrava- 
tion of tuberculosis (21), measles infection and mea- 
sles vaccine may also stimulate the immune system 
(22), for example, reducing prevalence and density of 
malaria parasitemia during acute infection (23). The 
net impact of such immune activation could be bene- 
ficial. 
The absence of excess post-measles mortality ques- 
tions current beliefs about measles infection and im- 
munization. If prevention of excess mortality after 
measles infection does not explain the marked reduc- 
tions in childhood mortality associated with standard 
measles vaccination (2- S), live measles vaccine may 
have nonspecific beneficial effects on the immune 
system, providing some protection against other infec- 
tions than measles (24, 25). The lack of increased 
post-measles mortality makes it unlikely that the re- 
duced survival after high-titer vaccine (6,9, 10) should 
be a result of persistent immunosuppression due to the 
vaccine (1 1, 13,26). Whereas high-titer vaccines were 
associated with reduced survival only for girls (6), 
there was no long-term difference in post-measles 
mortality by sex in the present study. Hence, an alter- 
native explanation of the surprising increase in mor- 
tality after high-titer measles vaccine could be that 
high-titer vaccine does not have the same beneficial 
effect as standard vaccine (25), an effect which may be 
particularly strong for girls (6, 27). 
In the Niakhar study, the net impact of measles was 
negative because acute mortality was high (14). How- 
ever, it should be noted that even if the eight acute and 
the three post-measles deaths were combined, there 
was no excess mortality for index cases compared with 
uninfected children. Although this may rarely occur in 
developing countries, the net impact of natural mea- 
sles might be beneficial in situations with no acute 
mortality and many index cases. If infections and 
immunizations can protect against more than the spe- 
cific disease, it is not enough to measure seroconver- 
sion after vaccination to decide on the best immuni- 
zation policy. It will be necessary to assess the total 
impact of a new vaccine ûn morbidity and mortality 
(28). 
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